Page last updated: 2024-10-27

fluorouracil and Bone Marrow Failure Disorders

fluorouracil has been researched along with Bone Marrow Failure Disorders in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Bone Marrow Failure Disorders: Inherited or acquired diseases characterized by insufficient and/or dysplastic blood cells.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jafek, JL1
Shakya, A1
Tai, PY1
Ibarra, A1
Kim, H1
Maddox, J1
Chumley, J1
Spangrude, GJ1
Miles, RR1
Kelley, TW1
Tantin, D1
Jones, M1
Chase, J1
Brinkmeier, M1
Xu, J1
Weinberg, DN1
Schira, J1
Friedman, A1
Malek, S1
Grembecka, J1
Cierpicki, T1
Dou, Y1
Camper, SA1
Maillard, I1

Other Studies

2 other studies available for fluorouracil and Bone Marrow Failure Disorders

ArticleYear
Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia.
    Experimental hematology, 2019, Volume: 76

    Topics: Animals; Bone Marrow; Bone Marrow Failure Disorders; CDX2 Transcription Factor; Cell Transformation,

2019
Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells.
    The Journal of clinical investigation, 2015, Volume: 125, Issue:5

    Topics: Anemia, Aplastic; Animals; Animals, Newborn; Bone Marrow Diseases; Bone Marrow Failure Disorders; Bo

2015